$958 Million is the total value of Rhenman & Partners Asset Management AB's 93 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 12.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LLY | Sell | LILLY ELI & CO | $32,193,920 | -8.3% | 88,000 | -9.3% | 3.36% | -8.7% |
ABC | Buy | AMERISOURCEBERGEN CORP | $28,667,830 | +34.1% | 173,000 | +27.2% | 2.99% | +33.6% |
MDT | Buy | MEDTRONIC PLC | $27,202,000 | +29.8% | 350,000 | +45.8% | 2.84% | +29.3% |
BSX | Sell | BOSTON SCIENTIFIC CORP | $27,067,950 | -9.7% | 585,000 | -15.8% | 2.82% | -10.0% |
REGN | Buy | REGENERON PHARMACEUTICALS | $26,695,130 | +11.4% | 37,000 | +15.6% | 2.78% | +11.0% |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $26,286,460 | +28.0% | 254,000 | +7.2% | 2.74% | +27.6% |
MRK | MERCK & CO. INC | $23,854,250 | +9.6% | 215,000 | 0.0% | 2.49% | +9.3% | |
GILD | GILEAD SCIENCES INC | $23,179,500 | +9.4% | 270,000 | 0.0% | 2.42% | +9.0% | |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $23,102,400 | -22.9% | 80,000 | -16.7% | 2.41% | -23.2% |
ANTM | Buy | ELEVANCE HEALTH INC | $23,083,650 | +5.5% | 45,000 | +12.5% | 2.41% | +5.2% |
THC | Buy | TENET HEALTHCARE CORP | $22,967,893 | +50.5% | 470,750 | +36.8% | 2.40% | +49.9% |
TMO | Sell | THERMO FISHER SCIENTIFIC INC | $22,027,600 | -18.4% | 40,000 | -23.8% | 2.30% | -18.7% |
HCA | Buy | HCA HEALTHCARE INC | $21,596,400 | +131.0% | 90,000 | +109.3% | 2.25% | +130.1% |
BDX | Sell | BECTON DICKINSON & CO | $21,106,900 | +5.2% | 83,000 | -2.4% | 2.20% | +4.9% |
ABBV | Sell | ABBVIE INC | $21,009,300 | -4.1% | 130,000 | -13.1% | 2.19% | -4.4% |
CI | Sell | CIGNA CORP NEW | $20,543,080 | -15.2% | 62,000 | -17.3% | 2.14% | -15.5% |
JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $20,391,680 | +7.8% | 128,000 | -2.7% | 2.13% | +7.5% |
UNH | Sell | UNITED HEALTH GROUP INC | $20,146,840 | -33.8% | 38,000 | -30.7% | 2.10% | -34.0% |
HUM | Sell | HUMANA INC | $19,975,410 | -18.7% | 39,000 | -11.4% | 2.08% | -18.9% |
PFE | PFIZER INC | $17,934,000 | +10.1% | 350,000 | 0.0% | 1.87% | +9.7% | |
JNJ | JOHNSON & JOHNSON | $17,665,000 | +1.5% | 100,000 | 0.0% | 1.84% | +1.2% | |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $17,348,450 | +11.6% | 73,000 | -2.7% | 1.81% | +11.2% |
BNTX | Buy | BIONTECH SEsponsored ads | $16,373,980 | +20.2% | 109,000 | +10.1% | 1.71% | +19.7% |
CVS | Sell | CVS HEALTH CORP | $15,935,490 | -25.2% | 171,000 | -24.0% | 1.66% | -25.5% |
COO | Buy | COOPER COS INC | $15,541,490 | +21.2% | 47,000 | +0.2% | 1.62% | +20.7% |
INSP | Sell | INSPIRE MED SYS INC | $15,364,680 | +25.1% | 61,000 | -3.2% | 1.60% | +24.7% |
MCK | Sell | MCKESSON CORP | $14,629,680 | -24.9% | 39,000 | -22.0% | 1.53% | -25.2% |
AXNX | Buy | AXONICS INC | $14,381,900 | -6.4% | 230,000 | +9.5% | 1.50% | -6.7% |
MRTX | Buy | MIRATI THERAPEUTICS INC | $13,593,000 | +2.5% | 300,000 | +52.2% | 1.42% | +2.1% |
DHR | Sell | DANAHER CORPORATION | $13,271,000 | -15.0% | 50,000 | -19.4% | 1.38% | -15.2% |
HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $13,224,000 | +7.3% | 240,000 | +1.3% | 1.38% | +7.0% |
ABT | ABBOTT LABS | $12,845,430 | +11.0% | 117,000 | 0.0% | 1.34% | +10.6% | |
EW | Buy | EDWARDS LIFESCIENCES CORP | $10,743,840 | +18.7% | 144,000 | +15.2% | 1.12% | +18.2% |
SILK | Buy | SILK RD MED INC | $10,351,782 | +51.5% | 195,871 | +26.4% | 1.08% | +51.0% |
APLS | Sell | APELLIS PHARMACEUTICALS INC | $10,342,000 | -22.3% | 200,000 | -9.1% | 1.08% | -22.5% |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $10,152,400 | +6.3% | 85,000 | +2.4% | 1.06% | +5.8% |
CYTK | Buy | CYTOKINETICS INC | $9,911,874 | +8.1% | 216,322 | +3.0% | 1.03% | +7.7% |
SWAV | Buy | SHOCKWAVE MEDICAL INC | $9,663,670 | +64.8% | 47,000 | +135.0% | 1.01% | +64.2% |
OM | Buy | OUTSET MED INC | $9,295,200 | +75.9% | 360,000 | +5.9% | 0.97% | +75.4% |
ISEE | Buy | IVERIC BIO INC | $9,206,300 | +5.4% | 430,000 | +17.8% | 0.96% | +5.1% |
IMCR | IMMUNOCORE HLDGS PLCads | $8,560,500 | -0.1% | 150,000 | 0.0% | 0.89% | -0.4% | |
PODD | INSULET CORP | $8,537,310 | +13.8% | 29,000 | 0.0% | 0.89% | +13.4% | |
RPRX | ROYALTY PHARMA PLC | $8,496,800 | -6.6% | 215,000 | 0.0% | 0.89% | -7.0% | |
PRVA | Buy | PRIVIA HEALTH GROUP INC | $8,402,700 | -9.4% | 370,000 | +33.6% | 0.88% | -9.7% |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $8,336,642 | -0.7% | 783,519 | +6.8% | 0.87% | -1.0% |
BIIB | Sell | BIOGEN INC | $8,307,600 | -10.6% | 30,000 | -8.5% | 0.87% | -10.9% |
RVNC | Buy | REVANCE THERAPEUTICS INC | $8,085,480 | -6.6% | 438,000 | +12.9% | 0.84% | -6.8% |
XNCR | XENCOR INC | $7,657,739 | -7.0% | 294,076 | 0.0% | 0.80% | -7.3% | |
TECH | New | BIO-TECHNE CORP | $7,459,200 | – | 90,000 | +100.0% | 0.78% | – |
IMGN | Buy | IMMUNOGEN INC | $7,440,000 | +13.9% | 1,500,000 | +36.4% | 0.78% | +13.5% |
NTRA | Buy | NATERA INC | $6,628,050 | +76.4% | 165,000 | +106.2% | 0.69% | +76.1% |
ITCI | INTRA-CELLULAR THERAPIES INC | $6,615,000 | +15.9% | 125,000 | 0.0% | 0.69% | +15.4% | |
KRTX | Buy | KARUNA THERAPEUTICS INC | $5,895,000 | +34.4% | 30,000 | +50.0% | 0.62% | +34.0% |
WST | Buy | WEST PHARMACEUTICAL SVSC INC | $5,883,750 | +50.4% | 25,000 | +47.1% | 0.61% | +49.8% |
ESPR | ESPERION THERAPEUTICS INC NE | $5,607,000 | -23.4% | 900,000 | 0.0% | 0.58% | -23.6% | |
VEEV | VEEVA SYS INC | $5,567,610 | -3.9% | 34,500 | 0.0% | 0.58% | -4.3% | |
IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $5,523,375 | +16.0% | 864,378 | +69.5% | 0.58% | +15.4% |
NVST | Buy | ENVISTA HOLDINGS CORPORATION | $5,515,146 | +16.2% | 163,800 | +13.9% | 0.58% | +15.7% |
EXAS | Buy | EXACT SCIENCES CORP | $5,446,100 | +106.1% | 110,000 | +44.7% | 0.57% | +105.1% |
OSH | New | OAK STR HEALTH INC | $5,377,500 | – | 250,000 | +100.0% | 0.56% | – |
SGEN | SEAGEN INC | $5,268,910 | +1.1% | 41,000 | 0.0% | 0.55% | +0.7% | |
OLK | OLINK HLDG ABsponsored ads | $4,933,618 | +38.5% | 194,390 | 0.0% | 0.52% | +38.1% | |
PHR | Buy | PHREESIA INC | $4,854,000 | +42.1% | 150,000 | +20.0% | 0.51% | +41.3% |
VRAY | VIEWRAY INC | $4,480,000 | +4.4% | 1,000,000 | 0.0% | 0.47% | +4.0% | |
R1 RCM INC | $4,139,100 | -38.0% | 378,000 | 0.0% | 0.43% | -38.2% | ||
AGL | AGILON HEALTH INC | $4,115,700 | -18.7% | 255,000 | 0.0% | 0.43% | -19.1% | |
IQV | New | IQVIA HLDGS INC | $4,097,800 | – | 20,000 | +100.0% | 0.43% | – |
ALKS | ALKERMES PLC | $3,919,500 | +15.1% | 150,000 | 0.0% | 0.41% | +14.6% | |
ALHC | Buy | ALIGNMENT HEALTHCARE INC | $3,822,000 | +5.0% | 325,000 | +18.2% | 0.40% | +4.7% |
GKOS | GLAUKOS CORP | $3,712,800 | -22.1% | 85,000 | 0.0% | 0.39% | -22.4% | |
MGTX | MEIRAGTX HLDGS PLC | $3,618,796 | -10.3% | 555,030 | 0.0% | 0.38% | -10.6% | |
TDOC | TELADOC HEALTH INC | $3,074,500 | -20.2% | 130,000 | 0.0% | 0.32% | -20.3% | |
RLAY | New | RELAY THERAPEUTICS INC | $2,988,000 | – | 200,000 | +100.0% | 0.31% | – |
ARVN | Buy | ARVINAS INC | $2,907,850 | +17.0% | 85,000 | +70.0% | 0.30% | +16.5% |
TXG | 10X GENOMICS INC | $2,733,000 | +34.0% | 75,000 | 0.0% | 0.28% | +33.2% | |
PHAT | PHATHOM PHARMACEUTICALS INC | $2,639,056 | +5.9% | 235,210 | 0.0% | 0.28% | +5.4% | |
SGMO | SANGAMO THERAPEUTICS INC | $2,574,800 | -28.5% | 820,000 | 0.0% | 0.27% | -28.6% | |
NVCR | NOVOCURE LTD | $2,567,250 | +3.8% | 35,000 | 0.0% | 0.27% | +3.5% | |
New | NUVALENT INC | $2,382,400 | – | 80,000 | +100.0% | 0.25% | – | |
MRSN | New | MERSANA THERAPEUTICS INC | $2,344,000 | – | 400,000 | +100.0% | 0.24% | – |
ALLO | ALLOGENE THERAPEUTICS INC | $2,138,600 | -38.9% | 340,000 | 0.0% | 0.22% | -39.2% | |
GTHX | G1 THERAPEUTICS INC | $2,009,100 | -49.1% | 370,000 | 0.0% | 0.21% | -49.2% | |
HCAT | HEALTH CATALYST INC | $1,913,400 | +20.5% | 180,000 | 0.0% | 0.20% | +20.5% | |
IONS | IONIS PHARMACEUTICALS INC | $1,888,500 | -14.5% | 50,000 | 0.0% | 0.20% | -14.7% | |
RIGL | RIGEL PHARMACEUTICALS INC | $1,837,622 | +105.8% | 1,225,081 | 0.0% | 0.19% | +104.3% | |
NTLA | INTELLIA THERAPEUTICS INC | $1,744,500 | -33.9% | 50,000 | 0.0% | 0.18% | -34.1% | |
STXS | STEREOTAXIS INC | $1,650,473 | +10.7% | 797,330 | 0.0% | 0.17% | +10.3% | |
ISRG | Sell | INTUITIVE SURGICAL INC | $1,326,750 | -89.2% | 5,000 | -90.0% | 0.14% | -89.3% |
NKTR | NEKTAR THERAPEUTICS | $1,243,000 | -39.9% | 550,000 | 0.0% | 0.13% | -40.1% | |
NKTX | NKARTA INC | $1,198,000 | -52.5% | 200,000 | 0.0% | 0.12% | -52.7% | |
EPIX | ESSA PHARMA INC | $945,000 | -30.0% | 375,000 | 0.0% | 0.10% | -29.8% | |
IGMS | New | IGM BIOSCIENCES INC | $850,500 | – | 50,000 | +100.0% | 0.09% | – |
RAPID MICRO BIOSYSTEMS INC | $339,000 | -61.3% | 300,000 | 0.0% | 0.04% | -62.0% | ||
GH | Exit | GUARDANT HEALTH INC | $0 | – | -65,000 | -100.0% | -0.34% | – |
PGNY | Exit | PROGYNY INC | $0 | – | -90,000 | -100.0% | -0.42% | – |
HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -130,000 | -100.0% | -0.85% | – |
ABMD | Exit | ABIOMED INC | $0 | – | -85,900 | -100.0% | -2.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
ALKERMES PLC | 40 | Q3 2023 | 3.3% |
LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR/A | 2023-11-13 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.